Product NDC: | 0555-0158 |
Proprietary Name: | Chlordiazepoxide Hydrochloride |
Non Proprietary Name: | Chlordiazepoxide Hydrochloride |
Active Ingredient(s): | 5 mg/1 & nbsp; Chlordiazepoxide Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0555-0158 |
Labeler Name: | Barr Laboratories Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA084768 |
Marketing Category: | ANDA |
Start Marketing Date: | 19760701 |
Package NDC: | 0555-0158-04 |
Package Description: | 500 CAPSULE in 1 BOTTLE (0555-0158-04) |
NDC Code | 0555-0158-04 |
Proprietary Name | Chlordiazepoxide Hydrochloride |
Package Description | 500 CAPSULE in 1 BOTTLE (0555-0158-04) |
Product NDC | 0555-0158 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Chlordiazepoxide Hydrochloride |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 19760701 |
Marketing Category Name | ANDA |
Labeler Name | Barr Laboratories Inc. |
Substance Name | CHLORDIAZEPOXIDE HYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |